36 filings
Page 2 of 2
8-K
o82sz
8 Apr 22
Departure of Directors or Certain Officers
5:27pm
8-K
k6slysf0y qs7s2
14 Mar 22
Other Events
4:35pm
8-K
wvkrib1y4a2n wcy
14 Mar 22
Spruce Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Updates
4:09pm
8-K
j1b u14r3
5 Jan 22
Spruce Biosciences Appoints Javier Szwarcberg, M.D., MPH as Chief Executive Officer
5:04pm
8-K
1oixnij3m03az ulc
15 Nov 21
Spruce Biosciences Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
12:00am
8-K
5m3uztp a6sj5qs5
15 Sep 21
Regulation FD Disclosure
9:01am
8-K
whvf99j qybuewvy
25 Aug 21
Regulation FD Disclosure
11:02am
8-K
35q41j2nai3xf u84
10 Aug 21
Spruce Biosciences Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
4:14pm
8-K
nsh 9iscrqlih
29 Jun 21
Departure of Directors or Certain Officers
4:12pm
8-K
8gz6gtjwlusemyz
24 May 21
Submission of Matters to a Vote of Security Holders
4:37pm
8-K
kjzdydj 4sw
12 May 21
Spruce Biosciences Reports First Quarter 2021 Financial Results and Provides Corporate Updates
4:09pm
8-K
vjbw7pio3xl6zy
22 Mar 21
Spruce Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Recent Corporate Updates
4:18pm
8-K
ep7xwsoj90iogsz exv
25 Feb 21
Departure of Directors or Certain Officers
11:00am
8-K
bsqcdxlukew
6 Jan 21
Spruce Biosciences Provides Corporate Update and Outlines Milestones for 2021
9:01am
8-K
aiy7h6u8
18 Nov 20
Spruce Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:07pm
8-K
0ve6ns0n5dphns pxlih
14 Oct 20
Spruce Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise
4:21pm